Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Donor Lymphocyte Infusion for Relapsed Acute Leukemia or Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation: A Single-Institute Retrospective Analysis.
Ogasawara M, Nozu R, Miki K, Sugimura S, Kojima K, Hidaka D, Ogasawara R, Okada K, Sugita J, Kobayashi N, Imamura M, Ota S. Ogasawara M, et al. Among authors: ogasawara r. Intern Med. 2024 Jan 15;63(2):197-205. doi: 10.2169/internalmedicine.1714-23. Epub 2023 May 24. Intern Med. 2024. PMID: 37225485 Free PMC article.
Development of progressive multifocal leukoencephalopathy after cord blood transplantation in a patient with refractory angioimmunoblastic T-cell lymphoma.
Aiba M, Okada K, Funakoshi T, Nozu R, Takahashi T, Ozu S, Hidaka D, Ogasawara R, Sugita J, Ogasawara M, Kobayashi N, Imamura M, Shizukawa H, Ota S. Aiba M, et al. Among authors: ogasawara r. J Infect Chemother. 2024 Feb 27:S1341-321X(24)00066-7. doi: 10.1016/j.jiac.2024.02.025. Online ahead of print. J Infect Chemother. 2024. PMID: 38423299
Non-age-related neoplastic loss of sex chromosome correlated with prolonged survival in real-world CBF-AML patients.
Mori A, Onozawa M, Hidaka D, Yokoyama S, Miyajima T, Yokoyama E, Ogasawara R, Izumiyama K, Saito M, Fujisawa S, Ota S, Kakinoki Y, Tsutsumi Y, Yamamoto S, Miyagishima T, Nagashima T, Iwasaki H, Kobayashi H, Haseyama Y, Kurosawa M, Morioka M, Teshima T, Kondo T. Mori A, et al. Among authors: ogasawara r. Int J Hematol. 2022 Feb;115(2):188-197. doi: 10.1007/s12185-021-03238-z. Epub 2021 Nov 5. Int J Hematol. 2022. PMID: 34739701
Dynamic change in peripheral blood WT1 mRNA levels within three cycles of azacitidine predict treatment response in patients with high-risk myelodysplastic syndromes.
Harada S, Onozawa M, Hidaka D, Yokoyama S, Senjo H, Takahashi S, Ogasawara R, Kanaya M, Mori A, Ota S, Kondo T, Teshima T. Harada S, et al. Among authors: ogasawara r. Ann Hematol. 2022 Jun;101(6):1239-1250. doi: 10.1007/s00277-022-04807-w. Epub 2022 Mar 8. Ann Hematol. 2022. PMID: 35257209
Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3-ITD positive AML.
Miyajima T, Onozawa M, Yoshida S, Miyashita N, Kimura H, Takahashi S, Yokoyama S, Matsukawa T, Goto H, Sugita J, Fujisawa S, Hidaka D, Ogasawara R, Mori A, Matsuoka S, Shigematsu A, Wakasa K, Kasahara I, Saga T, Hashiguchi J, Takeda Y, Ibata M, Yutaka T, Fujimoto K, Kondo T, Teshima T. Miyajima T, et al. Among authors: ogasawara r. Eur J Haematol. 2023 Oct;111(4):620-627. doi: 10.1111/ejh.14055. Epub 2023 Jul 19. Eur J Haematol. 2023. PMID: 37465857
Loss of nivolumab binding to T cell PD-1 predicts relapse of Hodgkin lymphoma.
Ogasawara R, Hashimoto D, Sugita J, Yamawaki F, Naka T, Mitsuhashi T, Takahashi S, Miyashita N, Okada K, Onozawa M, Matsuno Y, Teshima T. Ogasawara R, et al. Int J Hematol. 2020 Mar;111(3):475-479. doi: 10.1007/s12185-019-02737-4. Epub 2019 Sep 19. Int J Hematol. 2020. PMID: 31538325
112 results